
It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Brexit …

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …

The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of …

It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …

It’s Friday again, and the past week was populated with a host of riveting news and features from the life …

Among other things, it’s been a week characterised by safety failures as three of our most popular stories centred on …

With every week we draw closer to the event everyone in the UK is talking about – the general election. …

It’s been a bad week for several large pharmaceutical companies this week, with some major failures in clinical trials that …

It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …

In response to the announcement of a UK snap election, this week saw the release of the ABPI’s 2017 General …

Another week has whizzed round again as we race into Spring, and a breadth of stories have piqued the interests …

It’s Friday, and medical device recalls have been the flavour of the week, with both GSK and Mylan having to …

It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …

With the weekend on the horizon and a new issue of Pharmafocus hitting press, we review the most read, shared …

The past week in the industry has brought much hope for patients with the news of significant research data developments …